To view a copy of this licence, visit About this article Cite this article Gallardo-Nuell, L., Blanch, J., Leal, Y
A medicine that appears stronger in early research may still be the wrong option if it is unapproved, poorly monitored, or mismatched to a persons health history
He G, Cao Y, Ma H, et al
2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Funding No funding or sponsorship was received for this study or the publication of this article
(Midi does not prescribe this or other unapproved peptides.) What the science says: We need more long-term clinical human data on CJC-1295